CN101332246B - Traditional Chinese medicine preparation for treating coronary heart disease and angina - Google Patents

Traditional Chinese medicine preparation for treating coronary heart disease and angina Download PDF

Info

Publication number
CN101332246B
CN101332246B CN2008101506180A CN200810150618A CN101332246B CN 101332246 B CN101332246 B CN 101332246B CN 2008101506180 A CN2008101506180 A CN 2008101506180A CN 200810150618 A CN200810150618 A CN 200810150618A CN 101332246 B CN101332246 B CN 101332246B
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
heart disease
cases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101506180A
Other languages
Chinese (zh)
Other versions
CN101332246A (en
Inventor
蔡青
高建宏
李鸣
史峰庆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101506180A priority Critical patent/CN101332246B/en
Publication of CN101332246A publication Critical patent/CN101332246A/en
Application granted granted Critical
Publication of CN101332246B publication Critical patent/CN101332246B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine preparation for curing coronary heart disease and angina which is prepared by the following raw materials according to parts by weight: 18-22 parts of salvia miltiorrhiza, 4-6 parts of Sanchi, 17-23 parts of rubefacient, 13-18 parts of dalbergia wood, 13-18 parts of rhizoma corydalis, 7-11 parts of safflower, 18-22 parts of fleece-flower root, 25-35 parts of caulis spatholobi, 18-22 parts of myrrh, 13-17 parts of ginseng, 13-17 parts of cinnamon, 18-22 parts of epimedium, 4-6 parts of hairy deerhorn, 11-15 parts of glossy ganoderma, 7-9 parts of aweto, 12-18 parts of hemlock parsley, 8-12 parts of peach kernel, 13-17 parts of olibanum, 4-6 parts of scorpion, 4-6 of chilopod, 12-17 parts of the root bark of the peony tree. The preparation has the efficacy of activating Yang and removing obstruction and eliminating phlegm for resuscitation, and is suitable for relieving obstruction of Qi in chest, thoracic pain involving the back, serious pain and tesshin, cough, plenty sputum and breathless , tachycardia. 96 cases of the coronary heat disease are cured by the invention. 85 cases among the 96 cases have obvious effect, while 11 cases have no effect. The total effective rate is 88 percent. 87 cases are followed after the medicine is stopped eating for three months, which have no recurrence.

Description

Treatment coronary heart disease and anginal Chinese medicine preparation
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of coronary heart disease and anginal Chinese medicine preparation for the treatment of.
Background technology
Coronary heart disease is the abbreviation of coronary atherosclerotic heart disease.Being meant the blood vessel of supplying with the heart nutrient substance---serious atherosis or spasm takes place in coronary artery, make coronary stricture or obstruction, and thrombosis causes obliteration, causes a kind of heart disease of myocardial ischemia-anoxemia or infraction, also claims ischemic heart desease.Coronary heart disease is the common type that atherosclerosis causes organ lesion, also is the commonly encountered diseases of harm middle-aged and elderly people health.Degree and number that the generation of primary disease and coronary atherosclerosis are narrow have substantial connection, though the coronary atherosclerosis of minority young patient is not serious, even do not take place atherosisly, also can fall ill.Though also have some old people's coronary atherosclerotics narrow more serious, coronary heart disease clinical manifestations such as chest pain, cardiopalmus might not all be arranged.Therefore, cause of coronary heart disease mechanism is very complicated, as a whole, sees with organic more.Also multiple being born in of coronary vasospasm has atherosis coronary artery.
ACA comprises following several performance clinically:
1, sudden death.2, acute myocardial infarction.3, angina pectoris.4, acute left heart dysfunction, pulmonary edema.5, acute arrhythmia such as atrial fibrillation, multi-source pleiomorphism ventricular premature contraction, ventricular tachycardia, chamber quiver, severe sinus bradycardia, advanced A-V block etc.6, owing to acute myocardial ischemia, cardiac output can not cause the paroxysmal hypotension completely, faint.7, silent myocardial ischemia etc.The most serious in the above-mentioned performance with sudden death and two types of acute myocardial infarction.
Primary disease mostly occurred after 40 years old, and the male is more than the women, and the brain worker is more than physical labourer, and average prevalence is about 6.49%, and prevalence increases with the growth at age.Along with the influence of the life style of higher fatty acid, fast food, fast pace, high pressure, prevalence of coronary heart disease is the trend that rises year by year, and sicken age is tending towards rejuvenation.
Coronary heart disease has become the huge killer who has a strong impact on human health, does not have specific medicament at present for this disease treatment.
Summary of the invention
The object of the invention provides a kind of Chinese medicine preparation for the treatment of coronary heart disease.
Angina pectoris belongs to categories such as Chinese medicine " thoracic obstruction ", " angina pectoris ", " precordial pain with cold limbs ", " cardiopalmus ", and the traditional Chinese medical science is thought the generation of primary disease, many and inward invasion of pathogenic cold, and improper diet, factors such as disorder of emotion, body deficiency due to old age are relevant.As far back as " the Lei Zheng Zhi Cai thoracic obstruction " cloud: " thoracic obstruction, weakened YANG QI is not transported in the heart, for a long time then the yin subjugating yang position and be the numbness knot also ".It is main that Chinese traditional treatment coronary heart disease adopts blood circulation promoting and blood stasis dispelling, aromatic herbs activating YANG, supplementing QI and nourishing YIN, soothing the liver regulating QI etc. mostly, helps angry blood, and the capable then blood of gas is capable.
According to above theory, the present invention treats coronary heart disease and anginal Chinese medicine preparation, is to make with following weight portion raw material of Chinese medicine:
Radix Salviae Miltiorrhizae 18-22, Radix Notoginseng 4-6, Radix Paeoniae Rubra 17-23, Lignum Dalbergiae Odoriferae 13-18, Rhizoma Corydalis 13-18, Flos Carthami 7-11, Radix Polygoni Multiflori 18-22, Caulis Spatholobi 25-35, Myrrha 18-22, Radix Ginseng 13-17, Cortex Cinnamomi 13-17, Herba Epimedii 18-22, Cornu Cervi Pantotrichum 4-6, Ganoderma 11-15, Cordyceps 7-9, Rhizoma Chuanxiong 12-18, Semen Persicae 8-12, Olibanum 13-17, Scorpio 4-6, Scolopendra 4-6, Cortex Moutan 12-17.
The preferential prescription of recommending of the present invention:
Radix Salviae Miltiorrhizae 20, Radix Notoginseng 5, Radix Paeoniae Rubra 20, Lignum Dalbergiae Odoriferae 15, Rhizoma Corydalis 15, Flos Carthami 9, Radix Polygoni Multiflori 20, Caulis Spatholobi 30, Myrrha 20, Radix Ginseng 15, Cortex Cinnamomi 15, Herba Epimedii 20, Cornu Cervi Pantotrichum 5, Ganoderma 13, Cordyceps 8, Rhizoma Chuanxiong 15, Semen Persicae 10, Olibanum 15, Scorpio 5, Scolopendra 5, Cortex Moutan 15.
Side of the present invention separates:
Radix Notoginseng-hemostasia and dissipation blood stasis, subduing swelling and relieving pain;
Radix Salviae Miltiorrhizae-blood circulation promoting and blood stasis dispelling, relieving restlessness is calmed the nerves, reducing swelling and alleviating pain;
Radix Paeoniae Rubra-removing heat from blood and promoting blood circulation, stasis-dispelling and pain-killing, liver heat removing and eyesight improving;
Lignum Dalbergiae Odoriferae-clots absorbing pain relieving analgesic therapy;
Rhizoma Corydalis-promoting blood circulation to remove blood stasis, the promoting the circulation of QI pain relieving;
Flos Carthami-promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing;
Skin ulcer, preventing the attack (or recurrence) of malaria (give birth to and use) are controlled in Radix Polygoni Multiflori-invigorating the liver and kidney, benefiting essence-blood, relieving constipation;
Caulis Spatholobi-promoting the circulation of blood is enriched blood, relaxing muscles and tendons and activating QI and blood in the collateral;
Myrrha-promoting blood circulation and stopping pain,, detumescence and promoting granulation;
Radix Ginseng-QI invigorating emergency treatment of collapse is mended strengthening spleen and lung, promoting the production of body fluid to quench thirst, the Fructus Alpiniae Oxyphyllae of calming the nerves;
Cortex Cinnamomi-warming middle-JIAO YANG invigorating, dispersing cold for relieving pain;
Herba Epimedii-kidney invigorating and YANG supporting, expelling wind and removing dampness, blood pressure lowering, antitussive, eliminate the phlegm, relieving asthma;
Cornu Cervi Pantotrichum-kidney-replenishing, benefiting essence-blood, bone and muscle strengthening;
Ganoderma-invigorating QI and tranquilization, relieving cough and asthma;
Cordyceps-nourishing the lung and kidney, hemostasis and phlegm;
Rhizoma Chuanxiong-blood-activating and qi-promoting, wind-expelling pain-stopping;
Semen Persicae-removing blood stasis with potent drugs promoting the circulation of blood is moisturized laxation;
Olibanum-promoting blood circulation and stopping pain, detumescence and promoting granulation, secondary muscle is active;
Scorpio-relieving spasm by subduing liver-wind, activating collaterals to relieve pain, toxin expelling is treated skin ulcer;
Scolopendra-relieving spasm by subduing liver-wind, toxin expelling is treated skin ulcer;
Radix Paeoniae Rubra-removing heat from blood and promoting blood circulation, stasis-dispelling and pain-killing, liver heat removing and eyesight improving;
Cortex Moutan-clearing away heat and cooling blood, removing heat from the liver to lower the high blood pressure, activating blood circulation and dissipating blood stasis.
The present invention has activating YANG and eliminating stagnation, and the effect of the eliminating phlegm therapeutic method to keep the adverse QI flowing downwards adapts to the thoracic obstruction, chest pain radiating to the back, backache radiating to the heart, and cough, abundant expectoration are out of breath, tachycardia.Advantage is that compatibility is simple, and dosage is few, and each symptom of coronary heart disease is all produced effect.
The specific embodiment
Prescription 1 (unit: restrain, down together) Radix Salviae Miltiorrhizae 18, Radix Notoginseng 6, Radix Paeoniae Rubra 17, Lignum Dalbergiae Odoriferae 18, Rhizoma Corydalis 13, Flos Carthami 11, Radix Polygoni Multiflori 18, Caulis Spatholobi 35, Myrrha 18, Radix Ginseng 17, Cortex Cinnamomi 13, Herba Epimedii 22, Cornu Cervi Pantotrichum 4, Ganoderma 15, Cordyceps 7, Rhizoma Chuanxiong 18, Semen Persicae 8, Olibanum 17, Scorpio 4, Scolopendra 6, Cortex Moutan 12.
Prescription 2: Radix Salviae Miltiorrhizae 20, Radix Notoginseng 5, Radix Paeoniae Rubra 20, Lignum Dalbergiae Odoriferae 15, Rhizoma Corydalis 15, Flos Carthami 9, Radix Polygoni Multiflori 20, Caulis Spatholobi 30, Myrrha 20, Radix Ginseng 15, Cortex Cinnamomi 15, Herba Epimedii 20, Cornu Cervi Pantotrichum 5, Ganoderma 13, Cordyceps 8, Rhizoma Chuanxiong 15, Semen Persicae 10, Olibanum 15, Scorpio 5, Scolopendra 5, Cortex Moutan 15.
Prescription 3: Radix Salviae Miltiorrhizae 22, Radix Notoginseng 4, Radix Paeoniae Rubra 23, Lignum Dalbergiae Odoriferae 13, Rhizoma Corydalis 18, Flos Carthami 7, Radix Polygoni Multiflori 22, Caulis Spatholobi 25, Myrrha 22, Radix Ginseng 13, Cortex Cinnamomi 17, Herba Epimedii 18, Cornu Cervi Pantotrichum 6, Ganoderma 11, Cordyceps 9, Rhizoma Chuanxiong 12, Semen Persicae 12, Olibanum 13, Scorpio 6, Scolopendra 4, Cortex Moutan 17.
Above-mentioned prescription drug is crushed to 100 orders after mixing, and incapsulates sterilization and gets final product.
The present invention treats coronary heart disease 96 routine clinical summaries
Coronary heart disease is the commonly encountered diseases of middle-aged and elderly people, and frequently-occurring disease, this disease belong to Chinese medicine " thoracic obstruction ", " angina pectoris " category.Use preparation for treating coronary heart disease 96 examples of the present invention, obtain better curative effect, now be reported as follows:
1, the clinical data case is selected 96 examples, all by " coronary heart disease Chinese medical discrimination standard " execution of first national internal medicine academic conference cardiovascular diseases special interest group in 1980 " about the suggestion of coronary heart disease name and diagnostic criteria " and in October, 1 990 CAIM (Chinese Association Of Integrative Medicine) cardiovascular association revision, wherein male 59 examples, women 36 examples; At minimum 32 years old of age, maximum 71 years old, the course of disease is the longest 23 years, and was the shortest 0.5 year, 0.5~5 year 51 example wherein, 6~10 years 21 examples, 24 examples more than 20 years.Wherein coronary heart disease is with angina pectoris 67 examples
2, Therapeutic Method
2.1, basic side's medicine: adopt medicament capsule of the present invention, take every day 30 the gram, divide and take for three times.Two weeks is a course of treatment, general treatment 2-3 course of treatment, avoids exertion anger.
2.2, curative effect judging standard:
Studying forum " coronary heart disease efficacy assessment standard " according in JIUYUE, 1979 whole nation therapy of combining Chinese and Western medicine evaluates.
Produce effects: " breathe hard, pained transference cure or obviously alleviate, other double disease and electrocardiogram are stable or progressive to some extent.
Invalid: all diseases and electrocardiogram no change;
3, therapeutic effect
(1) with angina pectoris 67 examples, produce effects 59 examples, invalid 8 examples.
(2), quiver in other acute left heart dysfunction, pulmonary edema, acute arrhythmia such as atrial fibrillation, multi-source pleiomorphism ventricular premature contraction, ventricular tachycardia, chamber, severe sinus bradycardia etc. adds up to 29 examples, produce effects 26 examples, invalid 3 examples.
(3), add up to 96 examples, produce effects 85 examples, invalid 11 examples.
Treat all disease 96 examples of coronary heart disease, produce effects 85 examples, invalid 11 examples through the present invention.Total effective rate 88%.Follow up a case by regular visits to 87 examples in three months after the drug withdrawal, all do not have recurrence.

Claims (2)

1. treat coronary heart disease and anginal Chinese medicine preparation, it is characterized in that making with following weight portion raw material of Chinese medicine:
Radix Salviae Miltiorrhizae 18-22, Radix Notoginseng 4-6, Radix Paeoniae Rubra 17-23, Lignum Dalbergiae Odoriferae 13-18, Rhizoma Corydalis 13-18, Flos Carthami 7-11, Radix Polygoni Multiflori 18-22, Caulis Spatholobi 25-35, Myrrha 18-22, Radix Ginseng 13-17, Cortex Cinnamomi 13-17, Herba Epimedii 18-22, Cornu Cervi Pantotrichum 4-6, Ganoderma 11-15, Cordyceps 7-9, Rhizoma Chuanxiong 12-18, Semen Persicae 8-12, Olibanum 13-17, Scorpio 4-6, Scolopendra 4-6, Cortex Moutan 12-17.
2. treatment coronary heart disease according to claim 1 and anginal Chinese medicine preparation is characterized in that making with following weight portion raw material of Chinese medicine:
Radix Salviae Miltiorrhizae 20, Radix Notoginseng 5, Radix Paeoniae Rubra 20, Lignum Dalbergiae Odoriferae 15, Rhizoma Corydalis 15, Flos Carthami 9, Radix Polygoni Multiflori 20, Caulis Spatholobi 30, Myrrha 20, Radix Ginseng 15, Cortex Cinnamomi 15, Herba Epimedii 20, Cornu Cervi Pantotrichum 5, Ganoderma 13, Cordyceps 8, Rhizoma Chuanxiong 15, Semen Persicae 10, Olibanum 15, Scorpio 5, Scolopendra 5, Cortex Moutan 15.
CN2008101506180A 2008-08-02 2008-08-02 Traditional Chinese medicine preparation for treating coronary heart disease and angina Expired - Fee Related CN101332246B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101506180A CN101332246B (en) 2008-08-02 2008-08-02 Traditional Chinese medicine preparation for treating coronary heart disease and angina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101506180A CN101332246B (en) 2008-08-02 2008-08-02 Traditional Chinese medicine preparation for treating coronary heart disease and angina

Publications (2)

Publication Number Publication Date
CN101332246A CN101332246A (en) 2008-12-31
CN101332246B true CN101332246B (en) 2010-12-22

Family

ID=40195300

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101506180A Expired - Fee Related CN101332246B (en) 2008-08-02 2008-08-02 Traditional Chinese medicine preparation for treating coronary heart disease and angina

Country Status (1)

Country Link
CN (1) CN101332246B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101991616B (en) * 2009-08-13 2012-04-18 郝全得 Traditional Chinese medicine composite for coronary heart disease and angina pectoris and preparation method thereof
CN101850062B (en) * 2010-06-01 2011-08-17 姚桂英 Method for preparing Chinese medicament for treating heart-blood deficiency nodal tachycardia
CN102210743A (en) * 2011-05-26 2011-10-12 张兆俊 Formula of medicament for treating angina pectoris of coronary disease and preparation method of medicament for treating angina pectoris of coronary disease
CN102379980A (en) * 2011-09-16 2012-03-21 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic heart diseases
CN102600342B (en) * 2012-04-01 2013-10-02 任涛 Specific medicine for treating coronary disease
CN104013744B (en) * 2014-06-26 2015-02-18 贵阳医学院 Traditional Chinese medicine prescription for treating unstable angina pectoris of aged coronary heart disease
CN104474262A (en) * 2014-11-19 2015-04-01 济南伟传信息技术有限公司 Traditional Chinese medicine for treating stenocardia
CN104367954A (en) * 2014-11-19 2015-02-25 济南伟传信息技术有限公司 Traditional Chinese medicine decoction for treating angina
CN105327140A (en) * 2015-11-04 2016-02-17 柯小娥 Traditional Chinese medicine preparation with heart nourishing function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1891279A (en) * 2005-07-06 2007-01-10 陈克治 Capsule for treating cardio-cerebrovasular disease
CN1966050A (en) * 2006-11-20 2007-05-23 王顺祥 Medicament for treating heart disease and preparation process thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1891279A (en) * 2005-07-06 2007-01-10 陈克治 Capsule for treating cardio-cerebrovasular disease
CN1966050A (en) * 2006-11-20 2007-05-23 王顺祥 Medicament for treating heart disease and preparation process thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
杨建华.冠心病心绞痛的中药治疗.《四川中医》.1994,(第9期), *
马步升.冠心病心绞痛的中药治疗.《中医药信息》.1992,(第4期), *

Also Published As

Publication number Publication date
CN101332246A (en) 2008-12-31

Similar Documents

Publication Publication Date Title
CN101332246B (en) Traditional Chinese medicine preparation for treating coronary heart disease and angina
CN102247552A (en) Kudzuvine root and cinnamomvine capsules for cardiovascular and cerebrovascular diseases
CN100512852C (en) Composite Chinese medicine took orally for treating coronary heart disease
CN105012652A (en) Traditional Chinese medicinal prescription of 'quick-acting stasis and ache relieving powder' for treating coronary heart disease
CN101496892B (en) Oral Chinese patent medicine for treating cardiovascular disease
CN102836338B (en) Chinese medicament for treating cardia-cerebrovascular diseases
CN102048939B (en) Medicament for treating sinus bradycardia
CN102430085B (en) Chinese medicine for treating coronary heart disease
CN104606561A (en) Traditional Chinese medicinal composition for treating spontaneous perspiration
CN101024048A (en) Medicine for treating heart disease
CN102614462A (en) Traditional Chinese medicine composition for curing coronary disease and preparation method thereof
CN103285328B (en) Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof
CN105943797A (en) Medicine for preventing and treating cardiovascular diseases and preparation method thereof
CN105749216A (en) Traditional Chinese medicine wine for treating hypertension and preparation method thereof
CN101987135A (en) Medicine for treating tetanus and preparation method thereof
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN104784402A (en) Traditional Chinese medicine for treating cerebral arteriosclerosis
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN1814163A (en) Chinese medicine for treating cardiovascular and cerebrovascular trrombus and preparing method
CN112206279B (en) Traditional Chinese medicine composition for treating ventricular arrhythmia and preparation method and application thereof
CN103330911B (en) Chinese medicine powder for treating coronary heart disease and preparation method thereof
CN103127413B (en) Pharmaceutical preparation for treating coronary diseases
CN101983712A (en) Novel medicament for treating coronary heart disease
CN106237069A (en) A kind of Chinese medicine formula treating coronary heart disease
CN1225269C (en) Medicine for treating prospoalgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101222

Termination date: 20110802